1.

1 Introduction

Apollo Diagnostics, Vijayawada, is one of the leading clinical diagnostic laboratories in Andhra
Pradesh, providing comprehensive laboratory services for hospitals, physicians, healthcare
institutions, and individual patients. The laboratory is equipped with advanced automated
diagnostic platforms capable of performing thousands of investigations daily while maintaining
high standards of analytical accuracy, precision, and reliability. The institution follows
internationally accepted laboratory practices and quality management systems to ensure that
every diagnostic report generated is clinically dependable and contributes effectively to patient
care.

Modern healthcare relies heavily on laboratory medicine, as nearly 70% of clinical decisions are
influenced by laboratory test results. Accurate biochemical, microbiological, pathological, and
immunological investigations enable clinicians to diagnose diseases, monitor treatment efficacy,
predict disease progression, and evaluate patient prognosis. Therefore, diagnostic laboratories
function as an indispensable component of the healthcare delivery system.

Apollo Diagnostics employs highly trained laboratory professionals, pathologists,

microbiologists, and quality assurance personnel who work collaboratively to provide timely and
accurate diagnostic services. The laboratory follows Standard Operating Procedures (SOPs),
internal quality control (IQC), external quality assurance (EQA) programs, biosafety guidelines,
and laboratory accreditation standards to maintain consistency in analytical performance.

1.2 Objectives of the Internship

The internship was undertaken with the objective of bridging the gap between theoretical
knowledge acquired during academic coursework and practical applications in a modern clinical
diagnostic laboratory.

The major objectives included:

• To understand the complete workflow of a clinical diagnostic laboratory.

• To gain practical exposure to automated laboratory instrumentation.

• To study specimen collection, transportation, processing, and storage procedures.

• To understand the principles and applications of biochemical, serological,

microbiological, pathological, and histopathological investigations.

• To learn laboratory quality control and quality assurance procedures.

• To understand biosafety practices and biomedical waste management.

• To observe laboratory reporting systems and laboratory information management.

• To develop professional ethics, laboratory discipline, and technical competence.

1.3 Sample Receiving Area (SRA)

The Sample Receiving Area (SRA) is the first and one of the most critical sections of the laboratory.
Every patient specimen entering the laboratory passes through this department before being
distributed to specialized testing sections.
The major responsibilities of the SRA include:

• Verification of patient identity and requisition forms.

• Barcode generation and sample labeling.

• Registration in the Laboratory Information System (LIS).

• Verification of specimen type and collection container.

• Assessment of sample quality (hemolysis, clotting, inadequate volume, leakage).

• Prioritization of emergency (STAT) samples.

• Proper storage before analysis.

• Distribution of specimens to different laboratory departments.

1.4 Laboratory Departments

Biochemistry Department

The Biochemistry Department performs quantitative estimation of numerous biochemical

constituents present in blood, serum, plasma, urine, and other biological fluids.

During the internship, practical exposure was obtained in:Lipid Profile, Liver Function Test (LFT),
Kidney Function Test (KFT), Blood Glucose Estimation, HbA1c Analysis, Electrolyte Analysis,
Thyroid Function Test (T3, T4, TSH), Cardiac Biomarkers, Vitamin Assays, Routine Urine
Biochemistry

The department extensively utilized Roche Cobas automated analyzers, which perform high-
throughput biochemical and immunochemical investigations with minimal manual intervention.
These analyzers employ photometric, ion-selective electrode (ISE), and
electrochemiluminescence (ECL) technologies to provide rapid and highly accurate analytical
results.

Routine calibration, reagent management, preventive maintenance, and quality control

procedures were performed before patient sample analysis to ensure instrument reliability.

Microbiology Department

The Microbiology Department specializes in identifying microorganisms responsible for

infectious diseases.

Activities observed included: Specimen reception, Culture media preparation, Inoculation

techniques, Incubation procedures, Gram staining, Colony morphology examination,
Biochemical identification tests, Antibiotic susceptibility testing, Quality control procedures

Microbiological diagnosis plays an essential role in selecting appropriate antimicrobial therapy

and preventing antimicrobial resistance.

Clinical Pathology

Clinical Pathology deals with laboratory examination of urine, stool, semen, cerebrospinal fluid,
pleural fluid, ascitic fluid, and synovial fluid.
Training included: Physical examination, Chemical analysis using reagent strips, Urine
microscopy, Crystal identification, Cast identification, Cell counting, Detection of microorganis,
Documentation of pathological findings

Microscopic examination provides valuable information regarding renal disorders, urinary tract
infections, metabolic diseases, and systemic illnesses.

Histopathology

Histopathology is considered the gold standard for diagnosing many diseases, particularly
cancers.

Exposure included: Tissue fixation, Gross examination, Tissue processing, Paraffin embedding,
Microtomy, Hematoxylin and Eosin staining, Microscopic examination, Documentation of
pathological findings

Special emphasis was placed on documentation of uterine specimens, ovarian cysts, and
malignant tissue diagnosis under the supervision of experienced pathologists. Observation of
tissue architecture and cellular morphology demonstrated how histopathological evaluation
confirms disease diagnosis.

1.4.5 Serology

The Serology Department performs immunological investigations based on antigen-antibody

interactions.

Investigations commonly performed include: Hepatitis markers, HIV screening, Dengue, Typhoid,
Rheumatoid factor, CRP, Hormonal assays, Autoimmune markers

Automated immunoassay analyzers significantly improve diagnostic sensitivity and specificity

while reducing operator-dependent variability.

1.5 Biosafety Practices

Strict biosafety measures were followed throughout the internship.

These included:

• Wearing laboratory coats, gloves, masks, and protective equipment.

• Proper hand hygiene.

• Handling infectious specimens under biosafety precautions.

• Segregation of biomedical waste according to color coding.

• Safe disposal of sharps.

• Routine disinfection of work surfaces.

• Spill management procedures.

• Fire safety awareness.

• Emergency response protocols.

These practices protect laboratory personnel from occupational exposure and maintain a safe
working environment.
[Link] Review: Evolution of Modern Clinical Diagnostic Technology

Clinical laboratory diagnostics have experienced remarkable advancements over the past few
decades due to rapid developments in analytical chemistry, molecular biology, immunology,
automation, robotics, and information technology. Earlier laboratory investigations relied heavily
on manual analytical procedures that were labor-intensive, time-consuming, and susceptible to
human error. Although these methods formed the foundation of laboratory medicine, they were
limited by lower throughput, operator variability, and longer turnaround times.

The introduction of automated analyzers revolutionized diagnostic medicine by enabling

laboratories to process hundreds to thousands of patient samples within a short duration while
maintaining exceptional analytical precision. Modern automation minimizes manual pipetting,
improves reproducibility, standardizes testing procedures, and significantly reduces analytical
errors. Automated systems also incorporate barcode scanning, robotic sample handling, reagent
monitoring, and real-time quality control, thereby improving laboratory efficiency and patient
safety.

Clinical biochemistry has particularly benefited from advances in photometric analysis, ion-
selective electrode (ISE) technology, enzymatic assays, and electrochemiluminescence (ECL).
These analytical principles allow accurate measurement of glucose, electrolytes, liver enzymes,
renal biomarkers, lipid fractions, hormones, vitamins, and cardiac markers with high sensitivity
and specificity.

Electrochemiluminescence immunoassay (ECLIA) represents one of the most significant

innovations in immunodiagnostics. It combines antigen-antibody specificity with
electrochemically stimulated light emission, enabling rapid detection of hormones, tumor
markers, viral antigens, antibodies, and autoimmune biomarkers at extremely low
concentrations. Compared with conventional ELISA methods, ECLIA offers wider analytical
measuring ranges, greater sensitivity, improved precision, and shorter assay times.

Digital transformation has further improved laboratory management through Laboratory

Information Systems (LIS), which facilitate electronic test ordering, barcode-based sample
identification, automated result transfer, report generation, quality monitoring, and secure data
storage. Integration between automated analyzers and LIS minimizes transcription errors and
enhances workflow efficiency.

Quality assurance has also evolved considerably. Laboratories now implement Internal Quality
Control (IQC), External Quality Assurance (EQA), calibration verification, proficiency testing, and
accreditation standards such as ISO 15189 and NABL guidelines to ensure reliable analytical
performance. Continuous quality monitoring helps identify systematic errors before they affect
patient results.

In microbiology, the adoption of automated blood culture systems, rapid microbial identification
techniques, molecular diagnostics, and automated antimicrobial susceptibility testing has
significantly reduced the time required for pathogen identification and appropriate antibiotic
selection.

Histopathology has similarly progressed through automated tissue processors, automated

staining systems, digital pathology, and whole-slide imaging technologies, enabling more
standardized tissue preparation and improved diagnostic interpretation.
3. Material and Methods: Core Technical Infrastructure and Scientific Principles

The integrity of diagnostic data is predicated on a deep technical understanding of equipment

physics and the biochemical kinetics of the assays.

3.1 Automated Biochemistry and Immunology Platforms

The laboratory utilizes the Roche Cobas ecosystem as its primary analytical driver:

• Cobas c 311: A dedicated clinical

chemistry platform utilizing photometric assays
and Ion-Selective Electrode (ISE) measurements
for electrolytes (Sodium, Potassium, Chloride).
Operationally, the system utilizes an 80-sample
disk capacity. To ensure analytical stability,
specific disk assignments are strictly followed:
Positions 81-82 are reserved for Controls, 90-
98 for Calibrators, and 99-108 for STAT (urgent)
positions, allowing for immediate prioritization
of critical cases.

• Cobas e 411: This platform utilizes

Electrochemiluminescence (ECL)
technology, involving ruthenium complexes
and magnetic microparticles. This system
provides high-sensitivity detection for thyroid
profiles (T3, T4, TSH) and fertility markers.
Crucially, it is utilized for the quantification of
Prostate-Specific Antigen (PSA), a vital
marker for evaluating prostatic growth and
health, as well as sensitive viral markers.

In a high-volume clinical laboratory environment, the transition from manual sample handling to
automated diagnostic processing is a critical evolution. This Standard Operating Procedure (SOP)
serves as a strategic framework to ensure that visual interface data is transformed into a
structured, reproducible workflow. By implementing these rigorous protocols, the laboratory
minimizes the risks associated with manual entry and human error, establishing a benchmark for
technical consistency across both biochemistry and immunology departments.

Scope This procedure applies to all diagnostic operations conducted within Apollo Diagnostic
Laboratories. It specifically governs the utilization of the following automated systems:

• Biochemistry Operations: Cobas c 311 analyzer (Disk-based system).

• Immunology Operations: Cobas e 411 analyzer (Rack-based system).

Adherence to these protocols is mandatory to protect patient safety. By ensuring total data
integrity from the moment a sample is loaded to the final validation of results, the laboratory
maintains its commitment to clinical excellence and diagnostic accuracy.

2. Laboratory Infrastructure and System Architecture

The efficiency of clinical output depends on the strategic routing of patient samples to the
appropriate specialized equipment. Understanding equipment specialization is a necessity to
ensure proper test routing; for example, a Hormone panel (e.g., Thyroid Profile) must never be
misrouted to the Biochemistry disk.

System Capability Matrix

System Diagnostic
Core Test Panels
Designation Domain

RFT (Renal Function), LFT (Liver Function), Lipid Profile (CHOD-

PAP Method), Sugar Test (Fasting, Post, Random),
Cobas c 311 Biochemistry
Lipase/Amylase, Urine (Creatinine, Protein, Electrolytes), Iron
Studies, C-Reactive Protein.

Hormones (Thyroid Profile: T3, T4, TSH), FSH/LH, Prolactin, E2,

Cobas e 411 Immunology
Progesterone, Testosterone, PSA (Prostate), Growth Hormone.

Specialized HbA1c Infrastructure In addition to the primary analyzers, glycated hemoglobin

(HbA1c) testing is performed on the dedicated HLC-723GX platform. This system provides a
specialized assessment of a patient's three-month average sugar levels, separate from the
primary chemistry line.

Rigorous system identification prevents sample misdirection, ensuring that every specimen
enters the pre-analytical phase on the correct diagnostic path. Misidentifying a Thyroid Profile as
a routine chemistry sample, for instance, results in immediate processing delays and wasted
reagents.

3. Pre-Analytical Sample Loading and Loading Logic

The sample loading phase represents the primary interface between manual handling and
automation. The logic applied during this phase determines the prioritization and sequence of
the entire diagnostic run.

Interface-Specific Loading Protocols

While the underlying logic remains consistent across departments, the physical interface differs
between the Biochemistry and Immunology systems:

• Cobas c 311 (Disk-Based): Employs an 80-sample capacity disk.

• Cobas e 411 (Rack-Based): Utilizes racks in place of a disk, though loading positions
follow the same logic as the c 311.

Mandatory Positioning Logic:

1. Standard Capacity: Supports up to 80 routine samples.

 2. Control Positions: Slots 81 and 82 are strictly reserved for Control samples. QC must be
performed every day before testing patient samples.

3. Calibrator Positions: Slots 90 through 98 are dedicated to system calibrators.

4. STAT/Urgent Positions: Slots 99 through 108 are designated for STAT or urgent samples.

Impact on Turnaround Time (TAT) The designation of specific STAT positions (99–108) is a
strategic measure to reduce laboratory TAT. By utilizing these positions, urgent samples bypass
the standard processing queue, allowing for immediate prioritization and faster clinical reporting
for critical patients. This physical placement informs the digital tracking system of the sample's
priority status.

4. Digital Interface Navigation: The System Overview

The "System Overview" acts as the central nervous system for laboratory operations, providing
real-time visibility into the mechanical and chemical readiness of the analyzers. Technicians
must confirm system health before proceeding to active sampling.

Work Flow Guide Checklist

The digital workflow must be executed in the following sequential order:

• Maintenance: Verify all daily mechanical checks are complete.

• Sample Data Clear: Purge previous run data to ensure record integrity.

• Reagent Load List: Confirm all necessary reagents are physically and digitally registered.

• Calib/QC Load List: Verify the loading of required calibrators and controls.

• Parameter Download: Ensure the latest test parameters and reference ranges are
synced.

• Sample Tracking: Activate the monitoring interface for the current run.

Reagent and Consumable Status Monitoring

Technicians must monitor all active modules (PC1, CC1, PC2, and CC2) to prevent mid-run
interruptions.

• Reagent Volumes: Monitor all modules; while PC2/CC2 typically maintain 100%
readiness, PC1/CC1 must be checked against minimum thresholds (e.g., 89%–90%).

• Solid Waste: Monitor the waste level bar to ensure capacity for the run.

• Consumables (Cup & Tip): Verify counts (e.g., 153 Cups, 308 Tips) against projected
volume.

All system alerts and flags must be addressed and cleared before the analyzer moves from
standby to an active sampling state.

5. Real-Time Sample Tracking and Status Monitoring

Real-time monitoring allows technicians to identify processing bottlenecks immediately and

maintain throughput targets.

Position Status Legend

 • Processing (Green): Active analysis is underway.

• Completed (White with Checkmark): Analytical run finished; results pending review.

• Failed (Red): Analysis halted; requires immediate intervention.

• Wrong (W Icon): Indicates a mechanical or logic error requiring troubleshooting.

• Sample/Barcode Error (S or B Icons): Pre-analytical identification failure due to

unreadable or missing labels.

Sampling Logic and Bottleneck Identification The system may display statuses such as
"Waiting: 10 min" for specific Test IDs like TRIGL (Triglycerides). This delay is strategically
required for necessary incubation or chemical reaction phases and must not be interrupted.
Once the digital tracker confirms a "Completed" status, the sample transitions to the final phase
of result validation.

6. Post-Analytical Result Review and Data Validation

The laboratory technician is the final arbiter of data quality. No result is released to the clinical
record without a comprehensive review of both analytical and calculated data against
established benchmarks.

Data Review Procedures

1. Filter Selection: Toggle between "Routine View" for patients and "QC" for control
validation.

2. Columnar Analysis: Review the Result, Unit, and Alarm columns.

3. Linearity and Detection: The "Alarm" column is critical for identifying results that exceed
the linearity of the equipment. Technicians must assess flags to determine if a sample
requires dilution or if it falls below detection limits.

3.2.1 MISPA-i2 Immunoturbidimetric Analyzer

• The MISPA-i2 (Agappe

Diagnostics) is a semi-automated
immunoturbidimetric analyzer used for
the quantitative estimation of proteins
and immunological markers in serum
and urine. It provides rapid, accurate,
and reliable results with automated
calibration and quality control, making it
suitable for routine clinical laboratory
testing.

The analyzer works on the principle of

immunoturbidimetry. When a patient
sample containing the target antigen is
mixed with a reagent containing specific antibodies, antigen-antibody complexes are formed.
These complexes increase the turbidity of the solution. The analyzer measures the change in light
absorbance, and the turbidity is directly proportional to the concentration of the analyte.

WorkingThe sample and reagent are added to a reaction cuvette, where the antigen-antibody
reaction occurs. The optical system measures the increase in turbidity, and the instrument
automatically calculates and displays the analyte concentration using a calibration curve.

Major Tests Performed

1. Rheumatoid Factor (RF):

Detects Rheumatoid Factor (IgM autoantibody) in serum. Used for the diagnosis and monitoring
of Rheumatoid Arthritis and other autoimmune diseases.

Normal Reference Value

• < 20 IU/mL (may vary with laboratory standards)

2. Microalbumin:

Measures small amounts of albumin in urine using immunoturbidimetry. Used for the early
detection of diabetic nephropathy, chronic kidney disease, and hypertension-related renal
damage

• Urinary Albumin • Interpretation

• <30 mg/day • Normal

• 30–300 mg/day • Microalbuminuria

• >300 mg/day • Macroalbuminuria (Proteinuria)

3.2.2 HORIBA Yumizen HLC-723GX HbA1c Analyzer

The HORIBA Yumizen HLC-723GX is a fully

automated analyzer used for the quantitative
estimation of HbA1c (Glycated Hemoglobin) in
whole blood. It is primarily used for the diagnosis
and long-term monitoring of diabetes mellitus.

The analyzer works on the principle of High-

Performance Liquid Chromatography (HPLC)
using cation-exchange chromatography.
Hemoglobin fractions are separated based on
differences in their electrical charge. HbA1c is
separated from other hemoglobin variants, and its
concentration is measured by a photometric
detector. The HbA1c value is then expressed as a
percentage of total hemoglobin.

A small volume of EDTA whole blood is aspirated into the analyzer, where red blood cells are lysed
to release hemoglobin. The sample passes through a cation-exchange chromatography column,
which separates HbA1c from other hemoglobin fractions. The separated fractions are detected
photometrically, and the analyzer automatically calculates and reports the HbA1c percentage.

Interpretation

HbA1c (%) Interpretation

<5.7% Normal

5.7–6.4% Prediabetes

≥6.5% Diabetes Mellitus

<7.0% (known diabetic) Good glycemic control

>8.0% Poor glycemic control

HbA1c reflects the average blood glucose level over the previous 2–3 months, making it an
important marker for diagnosing diabetes and monitoring long-term glycemic control.

Clinical Significance

• Diagnosis of diabetes mellitus.

• Monitoring long-term blood glucose control (reflects average blood glucose over the
previous 2–3 months).

• Assessment of the effectiveness of diabetes treatment.

3.2.3 Automated Hematology Analyzer (CBC Analyzer)

The Automated Hematology Analyzer is used for performing Complete Blood Count (CBC)
tests on whole blood samples. It provides rapid and accurate analysis of blood cells, aiding in the
diagnosis and monitoring of various hematological disorders such as anemia, infections,
inflammation, and leukemia.

The analyzer works on the principles of

Electrical Impedance (Coulter Principle)
and Flow Cytometry with Light Scatter.

Electrical Impedance: Blood cells

passing through a small aperture produce
changes in electrical resistance. These
changes are counted to determine the
number and size of red blood cells (RBCs)
and platelets.

Flow Cytometry: White blood cells

(WBCs) are analyzed by directing a laser
beam through the cells. The scattered light
helps differentiate and classify various
WBC populations.
Whole blood collected in an EDTA tube is aspirated into the analyzer. The instrument
automatically dilutes the sample, lyses red blood cells for WBC analysis, counts blood cells using
electrical impedance and flow cytometry, measures hemoglobin photometrically, and generates
a Complete Blood Count (CBC) report within a few minutes.

Major Parameters and Normal Reference Values

Parameter Normal Value

Male: 13.5–17.5 g/dL; Female: 12.0–15.5

Hemoglobin (Hb)
g/dL

Male: 4.5–5.9 ×10⁶/µL; Female: 4.1–5.1

RBC Count
×10⁶/µL

WBC Count 4,000–11,000 cells/µL

Platelet Count 150,000–450,000/µL

Hematocrit (HCT) Male: 41–53%; Female: 36–46%

Mean Corpuscular Volume (MCV) 80–100 fL

Mean Corpuscular Hemoglobin (MCH) 27–33 pg

Mean Corpuscular Hemoglobin Concentration

32–36 g/dL
(MCHC)

Clinical Significance

• Low Hemoglobin/RBC: Indicates anemia or blood loss.

• High WBC Count: Suggests infection, inflammation, or leukemia.

• Low WBC Count: May indicate viral infections or bone marrow disorders.

• Low Platelet Count: Increases the risk of bleeding.

• High Platelet Count: May be associated with inflammation or myeloproliferative

disorders.

3.3 Serological Tests performed

1. Widal Test

The Widal test is a slide/tube agglutination test based on the principle of antigen-antibody
reaction. Serum from a patient suspected of typhoid fever is mixed with standardized Salmonella
antigens (O and H antigens). If specific antibodies are present, visible agglutination (clumping)
occurs.

Reaction:

Antibody (Patient Serum) + Salmonella Antigen → Agglutination

Procedure

1. Collect blood and separate serum.

2. Place one drop of serum on the test slide.

3. Add one drop of O antigen and H antigen separately.

4. Mix using separate applicator sticks.

5. Gently rotate the slide for one minute.

6. Observe for visible agglutination.

For quantitative testing, serial serum dilutions are prepared in test tubes to determine antibody
titre.

Interpretation

Result Interpretation

No agglutination Negative

Agglutination with O antigen Current or recent infection

Agglutination with H antigen Past infection or vaccination

Significant titre (≥1:160)* Suggestive of Typhoid Fever

Clinical Significance

• Diagnosis of Typhoid Fever

• Detection of Salmonella Typhi infection

2. Dengue Test (Rapid Card Test)Most rapid dengue kits use Immunochromatographic Lateral
Flow [Link] test detects:

• NS1 Antigen

• IgM antibody

• IgG antibody

Patient sample migrates along the membrane where antigen-antibody complexes are captured
by immobilized antibodies producing a coloured line.

Procedure

1. Add serum/plasma/whole blood into sample well.

2. Add assay buffer.

3. Wait 15–20 minutes.

4. Read coloured bands.

Interpretation

Result Interpretation

C line only Negative

C + NS1 Early Dengue infection

C + IgM Recent infection

C + IgG Past or secondary infection

No Control Line Invalid test

Clinical Significance

• Early diagnosis of Dengue

• Detection during acute infection

• Monitoring immune response

3. HIV TestRapid HIV kits work on the principle of Immunochromatographic Assay (ICT).

The test detects antibodies against:

• HIV-1

• HIV-2

Some fourth-generation kits also detect p24 antigen.

Procedure

1. Add blood/serum/plasma.

2. Add buffer.

3. Wait 15 minutes.

4. Observe coloured bands.

Interpretation

Result Interpretation

Control line only Negative

Control + Test line Positive

No Control line Invalid

Positive samples require confirmation using ELISA or PCR.

Clinical Significance

• Screening for HIV infection

• Blood donor screening

• Antenatal screening

4. Hepatitis B Surface Antigen (HBsAg)

HBsAg rapid tests also use Lateral Flow Immunochromatography.

HBsAg present in serum binds with monoclonal antibodies coated on the membrane producing
a coloured line.

Procedure

1. Add serum/plasma.

2. Add assay buffer.

3. Wait 15 minutes.

4. Observe colour development.

Interpretation

Result Interpretation

Control only Negative

Control + Test Positive for Hepatitis B infection

No Control Invalid

Clinical Significance

• Detects active Hepatitis B infection

• Blood donor screening

• Antenatal screening

5. Hepatitis C Virus (HCV) Rapid HCV kits detect antibodies against Hepatitis C Virus using
Immunochromatographic Assay.

Procedure

1. Add serum/plasma.

2. Add buffer.

3. Wait 15–20 minutes.

4. Observe coloured bands.

Interpretation

Result Interpretation

Control only Negative

Control + Test HCV antibody positive

No Control Invalid

Positive samples require ELISA or PCR confirmation.

Clinical Significance

• Screening for Hepatitis C

• Blood donor screening

• Monitoring chronic liver disease

6. Syphilis Test

Principle

Rapid Syphilis kits detect antibodies against Treponema pallidum using

Immunochromatographic Assay.

Procedure

1. Add serum/plasma.

2. Add assay buffer.

3. Wait approximately 15 minutes.

4. Observe coloured bands.

Interpretation

Result Interpretation

Control only Negative

Control + Test Positive

No Control Invalid

Positive results are confirmed by TPHA or VDRL.

Clinical Significance

• Diagnosis of Syphilis

• Antenatal screening

• Blood donor screening

4. Practical Findings: Clinical Data and Operational Methodology

Diagnostic reliability is maintained through a "Gold Standard" of Daily Quality Control (QC) and
calibration, ensuring every result falls within strict statistical deviations before clinical release.

4.1 Clinical Reference Ranges and Parameter Analysis

The following parameters and reference ranges, extracted from validated laboratory logs, form
the basis for clinical interpretation:

Profile Parameter Reference Range Units

Renal Function (RFT) Creatinine 0.7 - 1.2 mg/dL

eGFR 60 - 150 mL/min/1.73m²

Urea 13 - 43 mg/dL

Blood Urea Nitrogen (BUN) 8 - 23 mg/dL

Uric Acid 3.5 - 7.2 mg/dL

Calcium 8.6 - 10.0 mg/dL

Phosphorus 2.5 - 4.5 mg/dL

Chloride 98 - 107 mmol/L

Total Protein 6.4 - 8.3 g/dL

Liver Function (LFT) Total Bilirubin 0 - 1.2 mg/dL

Direct Bilirubin 0 - 0.30 mg/dL

Indirect Bilirubin Calculated mg/dL

SGPT (ALT) 21 - 72 U/L

SGOT (AST) 10 - 50 U/L

SGPT/SGOT Ratio 0 - 1.15 ratio

Alkaline Phosphatase 40 - 129 U/L

Albumin 3.5 - 5.2 g/dL

Lipid Profile Total Cholesterol 0 - 200 mg/dL

Triglycerides 0 - 150 mg/dL

HDL Cholesterol 40 - 100 mg/dL

LDL Cholesterol Calculated mg/dL

Diabetic Markers Fasting Blood Sugar 70 - 100 mg/dL

 Post-Prandial Sugar 70 - 140 mg/dL

HbA1c (3-month avg) < 5.7 %

4.2 System Interface and Pre-Analytical Quality Control

The laboratory utilizes a Laboratory Information System (LIS) to manage sample registration,
barcode generation, test allocation, instrument connectivity, and report generation. Every
sample is assigned a unique barcode, enabling accurate tracking throughout the diagnostic
process. The system displays the status of each sample, such as Pending, Processing,
Completed, or Verified, allowing laboratory personnel to monitor workflow efficiently.

The LIS also assists in identifying pre-analytical errors by generating alerts for issues such as
barcode mismatches, incorrect patient information, insufficient sample volume, hemolyzed
specimens, clot formation, or unsuitable sample containers. Samples with such discrepancies
are withheld from analysis until the issue is resolved. This process minimizes pre-analytical
errors, improves traceability, and ensures that only valid samples are processed for diagnostic
testing.

4.3 Laboratory Safety and Pathogen Control

Apollo Diagnostics follows standard biosafety practices and the Biomedical Waste
Management (BMWM) Rules, 2016 for the safe handling and disposal of laboratory waste.
Laboratory personnel consistently use personal protective equipment (PPE), including laboratory
coats, gloves, face masks, and protective eyewear whenever necessary.

Biomedical waste generated during diagnostic procedures is segregated into color-coded

containers according to BMWM guidelines. Yellow biohazard bags are used for the disposal of
infectious waste such as contaminated swabs, culture materials, and other biological waste,
while sharps and plastic waste are disposed of in their respective designated containers. Work
surfaces and laboratory equipment are routinely disinfected, and proper hand hygiene is
maintained before and after specimen handling. These biosafety measures minimize the risk of
laboratory-acquired infections and maintain a safe working environment.

5. Discussion: Impact of Automation on Clinical Diagnostics

Automation has significantly improved the efficiency, accuracy, and reliability of modern clinical
laboratories. Automated analyzers reduce manual handling, minimize analytical variability, and
enable high-throughput processing of patient samples. This results in shorter turnaround times,
allowing clinicians to make timely diagnostic and therapeutic decisions.

During the internship, exposure to automated platforms such as the Roche Cobas series,
HORIBA Yumizen HbA1c Analyzer, MISPA-i2 Immunoturbidimetric Analyzer, MISPA-i3 Urine
Analyzer, and automated hematology analyzers demonstrated how different technologies
contribute to comprehensive patient diagnosis.

Advanced analytical techniques such as Electrochemiluminescence Immunoassay (ECLIA),

High-Performance Liquid Chromatography (HPLC), Ion-Selective Electrode (ISE),
Photometry, and Immunoturbidimetry provide highly sensitive and precise measurements for
hormones, infectious disease markers, electrolytes, proteins, HbA1c, and various biochemical
parameters.
Automation also improves laboratory quality through barcode-based sample identification,
automated calibration, internal quality control, and direct integration with the Laboratory
Information System (LIS). These features reduce transcription errors, improve data management,
and ensure reliable reporting, ultimately contributing to improved patient care.

6. Conclusion and Professional Reflection

The two-month internship at Apollo Diagnostics, Vijayawada, provided valuable practical

exposure to the functioning of a modern clinical diagnostic laboratory. It strengthened my
understanding of laboratory workflows, specimen processing, quality assurance, biosafety
practices, and the operation of advanced diagnostic instruments used in clinical biochemistry,
hematology, serology, clinical pathology, microbiology, and histopathology.

Hands-on exposure to automated platforms such as the Roche Cobas analyzers, HORIBA
Yumizen HLC-723GX, MISPA-i2, MISPA-i3, and automated hematology analyzers enhanced my
knowledge of various analytical principles, including Electrochemiluminescence
Immunoassay (ECLIA), High-Performance Liquid Chromatography (HPLC),
Immunoturbidimetry, Flow Cytometry, Electrical Impedance, Ion-Selective Electrode (ISE),
and Photometric Analysis. I also developed practical skills in sample handling, calibration,
quality control procedures, and interpretation of laboratory reports.

The internship emphasized the importance of accuracy, precision, ethical laboratory practices,
teamwork, and adherence to standard operating procedures in ensuring reliable diagnostic
results. This experience successfully bridged the gap between theoretical learning and practical
laboratory applications, providing a strong foundation for my future career in clinical diagnostics,
biomedical research, and healthcare laboratory management.
7. References

1. Bishop, M. L., Fody, E. P., & Schoeff, L. E. (2020). Clinical Chemistry: Principles,
Techniques, and Correlations (9th ed.). Wolters Kluwer.

2. McPherson, R. A., & Pincus, M. R. (2021). Henry's Clinical Diagnosis and Management by
Laboratory Methods (24th ed.). Elsevier.

3. Tietz, N. W. (2018). Tietz Textbook of Clinical Chemistry and Molecular Diagnostics (6th
ed.). Elsevier.

4. Roche Diagnostics. Cobas c 311 Analyzer – Operator's Manual.

5. Roche Diagnostics. Cobas e 411 Analyzer – Operator's Manual.

6. Agappe Diagnostics Ltd. MISPA-i2 Immunoturbidimetric Analyzer – User Manual and

MISPA-i3 Urine Analyzer – User Manual.

7. HORIBA Medical. Yumizen HLC-723GX HbA1c Analyzer – Operator's Manual.

8. World Health Organization (WHO). (2020). Laboratory Biosafety Manual (4th ed.).

9. Apollo Diagnostics. Standard Operating Procedures (SOPs) and Quality Management

System Manual.

10. Apollo Diagnostics, Vijayawada. Clinical Laboratory Training Records, Instrument Logs,
and Laboratory Information System (LIS) Documentation (May–July 2026).